New Jersey § 26:2s-38

§ 26:2s-38.

a. A carrier shall ensure that every contract to provide prescription drug benefits,

or to authorize the purchase of a contract to provide prescription drug benefits,

shall provide coverage for an opioid antidote to covered persons without the imposition

of any prior authorization or other utilization management requirements, provided

that the drug is: (1) prescribed or administered to the covered person by a licensed medical practitioner

who is authorized to prescribe or administer that treatment pursuant to State and

federal law; or (2) dispensed to the covered person by a licensed pharmacist under a standing order

to dispense an opioid antidote pursuant to section 1 of P.L.2017, c. 88 ( C.45:14-67.2 ). b. The provisions of this section shall not be construed to limit the coverage of

an opioid antidote only when administered by a medical practitioner. c. As used in this section: “ Carrier ” means an insurance company, health service corporation, hospital service corporation,

medical service corporation, or health maintenance organization authorized to issue

health benefits plans in this State. “ Opioid antidote ” means naloxone hydrochloride, or any other similarly acting drug approved by the

United States Food and Drug Administration for self-administration for the treatment

of an opioid overdose.